In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called ...

A nonprofit headed by Anne Wojcicki, the 51-year-old co-founder and former CEO of genetic testing startup 23andMe, is the new buyer for 23andMe's assets.

Anne Wojcicki regains control of 23andMe, the company she co-founded and led as CEO, through her nonprofit TTAM with a $305 million bid at a bankruptcy auction.

23andMe co-founder and former CEO Anne Wojcicki is set to buy back the company through a nonprofit public benefit corporation, TTAM Research Institute.

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday.

Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron ...

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne Wojcicki.

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ -0.51%, is poised to regain control of the DNA-testing company after a nonprofit she controls topped a prior bid. 23andMe said Friday ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction.

23andMe could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.